Literature DB >> 15515577

Identification and characterization of an idiopathic pulmonary fibrosis-like condition in cats.

Leah A Cohn1, Carol R Norris, Eleanor C Hawkins, Janice A Dye, Cheri A Johnson, Kurt J Williams.   

Abstract

Interstitial lung diseases are a heterogeneous group of disorders with a variety of causes. In veterinary medicine, such lung diseases with a prominent fibrotic component of unknown etiology are often called idiopathic pulmonary fibrosis (IPF). In human medicine, this term is reserved for a distinct disease entity with specific histologic findings labeled as usual interstitial pneumonia (UIP). We identified 23 cats displaying histologic criteria of UIP The purpose of this retrospective study is to describe the presentation and response to therapy of these cats to better define this disease entity. All but 2 cats were middle aged to older (median 8.7 years), with no apparent sex or breed predisposition. Complaints included respiratory distress (n = 18) and cough (13). Duration of signs was less than 6 months in 17 cats. Physical-examination abnormalities included tachypnea, inspiratory or mixed inspiratory and expiratory effort, and adventitial lung sounds. No consistent hematologic or biochemical abnormalities, parasites, or positive serologic results for feline retroviruses, heartworms, or toxoplasmosis were present. Radiographic changes included dense patchy or diffuse interstitial, bronchiolar, and alveolar infiltrates. Analysis of bronchial lavage fluid revealed mild neutrophilic inflammation (n = 6) with no consistent pathogen growth. Clinical condition of 5 cats worsened after lavage. Coincident pulmonary neoplasia was identified in 6 cats. Response to therapy (corticosteroids, antibiotics, bronchodilators, and diuretics) was poor, and most cats died within days to months. Cats with histologic changes compatible with UIP had signs that mimicked many of the clinical findings of human IPF, and treatment response was similarly unrewarding.

Entities:  

Mesh:

Year:  2004        PMID: 15515577     DOI: 10.1892/0891-6640(2004)18<632:iacoai>2.0.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  7 in total

1.  Modulation of lung inflammation by the Epstein-Barr virus protein Zta.

Authors:  James F Guenther; Jennifer E Cameron; Hong T Nguyen; Yu Wang; Deborah E Sullivan; Bin Shan; Joseph A Lasky; Erik K Flemington; Gilbert F Morris
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-03       Impact factor: 5.464

2.  Clinical, computed tomographic and histopathological findings in two cats with pulmonary fibrosis of unknown aetiology.

Authors:  Eleanor C Duffy; Sally Griffin; Erin M O'Connell; Jeremy R Mortier
Journal:  JFMS Open Rep       Date:  2020-11-05

Review 3.  Animal models of fibrotic lung disease.

Authors:  Bethany B Moore; William E Lawson; Tim D Oury; Thomas H Sisson; Krishnan Raghavendran; Cory M Hogaboam
Journal:  Am J Respir Cell Mol Biol       Date:  2013-08       Impact factor: 6.914

4.  Perspectives in veterinary medicine: Description and classification of bronchiolar disorders in cats.

Authors:  Carol R Reinero; Isabelle Masseau; Megan Grobman; Aida Vientos-Plotts; Kurt Williams
Journal:  J Vet Intern Med       Date:  2019-04-13       Impact factor: 3.333

5.  Reversibility of clinical and computed tomographic lesions mimicking pulmonary fibrosis in a young cat.

Authors:  Alba Stavri; Isabelle Masseau; Carol R Reinero
Journal:  BMC Vet Res       Date:  2021-12-09       Impact factor: 2.741

6.  Computed tomography imaging of a leopard tortoise (Geochelone pardalis pardalis) with confirmed pulmonary fibrosis: a case report.

Authors:  Chee Kin Lim; Robert M Kirberger; Emily P Lane; Dorianne L Elliott
Journal:  Acta Vet Scand       Date:  2013-04-23       Impact factor: 1.695

7.  Aetiology and outcome in 90 cats presenting with dyspnoea in a referral population.

Authors:  S Swift; J Dukes-McEwan; S Fonfara; J F Loureiro; R Burrow
Journal:  J Small Anim Pract       Date:  2009-09       Impact factor: 1.522

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.